NCT00465985 - Efficacy, Safety, and Tolerability of ACZ885 in Patients With Muckle-Wells Syndrome | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

October 31, 2008

Conditions

Muckle Wells Syndrome

Interventions

DRUG

ACZ885

DRUG

Placebo

Trial Locations (12)

Novartis Investigative Site, Madison

Novartis Investigative Site, Chicago

Novartis Investigative Site, San Francisco

Novartis Investigative Site, Le Kremlin-Bicêtre

Novartis Investigational Site, Lille

Novartis Investigative Site, Montpellier

Novartis Investigative Site, Nantes

Novartis Investigative Site, Paris

Novartis Investigative Site, Tübingen

Novartis Investigative Site, New Delhi

Novartis Investigative Site, Barcelona

Novartis Investigative Site, London